Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

That is the title of an article in AJMC co-authored with Meena Venkatachalam. An excerpt is below: While decision-makers traditionally have ignored the issue of inequality, academic researchers have already developed tools to quantify a treatment’s value from reductions in inequality. Two common methods for doing so are distributional cost effectiveness analysis (DCEA) and multiple-criteria…

Network meta-analysis of sickle cell disease treatments

“Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis” is the title of a paper recently published in BMJ Open with co-authors Howard Thom, Jeroen Jansen, Lauren Zhao, George Joseph, Hung-Yuan Cheng, Subhajit Gupta, and Nirmish Shah. The abstract is below. Objectives Treatment options for preventing vaso-occlusive crises (VOC) among…

Multiple sclerosis patient treatment preferences and health outcomes

Who knows best, patients or physicians? Clearly, physicians have medical knowledge that patients do not. On the other hand, patients have their own preferences balancing treatment safety, efficacy, convenience and other factors. Further, physicians may be more familiar with older less effective treatments compared to newer more effective treatments. One interesting question is how health…